DNA mapping and sequencing on linearized DNA molecules
AssigneeDrexel University
InventorsMing Xiao, Dharma Teja Varapula, Eric Michael LaBouff, Moses Noh
Life of this patent
Estimating the term…
Loading patent…
AssigneeDrexel University
InventorsMing Xiao, Dharma Teja Varapula, Eric Michael LaBouff, Moses Noh
Estimating the term…
The present invention provides novel methods for immobilizing and/or optically mapping oligonucleotides, the method comprising immobilizing the oligonucleotides on a micropatterned substrate. In another aspect, the invention provides a method for mapping a genome, wherein the method is capable of resolving a single nucleotide polymorphism (SNP), the method comprising introducing to the genome a CRISPR/Cas9 system comprising at least one single-guide RNA (sgRNA) specific for a target sequence or a plurality of target sequences across the genome and a Cas9 D10A, wherein the CRISPR/Cas9 system nick labels the target sequence, and the target sequence or genome is analyzed.
A method of immobilizing and linearizing an oligonucleotide, the method comprising:
A method of optically mapping DNA, the method comprising:
A method of on surface DNA sequencing library generation, the method comprising:
A method of DNA sequencing library generation, the method comprising:
A method of on surface DNA sequencing library generation, the method comprising:
A method of on surface DNA sequencing, the method comprising:
A method for mapping a genome, wherein the method is capable of resolving a single nucleotide polymorphism (SNP), the method comprising introducing to the genome a CRISPR/Cas9 system comprising at least one single-guide RNA (sgRNA) specific for a target sequence or a plurality of target sequences across the genome, wherein the CRISPR/Cas9 system labels the target sequence, and the target sequence or genome is analyzed.
A method of defining a long distance haplotype in a genome, the method comprising administering to the genome a CRISPR/Cas9 system and a plurality of single-guide RNAs (sgRNAs) specific for a plurality of loci of a genomic region or a plurality of target regions across the genome, wherein the CRISPR/Cas9 system labels the plurality of loci of the genomic region or the plurality of target regions across the genome, and the target sequence or genome is analyzed thereby defining the long distance haplotype in the genome.
Dependencies are inferred from the claim text.